Elago, Margaux Candice .

HRN: 15-76-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
CEFUROXIME 750MG (VIAL)
02/03/2024
02/09/2024
IV
730mg
Q8h
URTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: